Skip to main content
. 2018 Nov 4;10(11):1663. doi: 10.3390/nu10111663

Table 3.

ORs (95% CI) for metabolic syndrome and its components according to the quartiles of heme iron intake (mg/day) among all participants in the SDHS 2012–2013.

Quartiles of Dietary Iron Intake, ORs (95% CI)
Q1 Q2 Q3 Q4 p-Value for Trend 1
Heme Iron Intake (mg/day) <0.83 (0.83–1.28) (1.28–1.94) ≥1.94
n 776 774 773 776
Metabolic syndrome
   Crude model Reference 0.91(0.72,1.15) 0.92(0.73,1.16) 0.85(0.67,1.07) 0.593
    Adjusted model 2 Reference 1.06(0.82,1.36) 1.11(0.86,1.44) 1.06(0.80,1.39) 0.895
p-Value for interaction 3 = 0.096
Metabolic syndrome components
  Elevated blood pressure
   Crude model Reference 0.76(0.64,0.91) ** 0.73(0.61,0.87) ** 0.73(0.61,0.87) ** 0.001
   Adjusted model 2 Reference 0.91(0.74,1.13) 0.98(0.79,1.22) 1.05(0.83,1.32) 0.620
  Elevated waist circumference
   Crude model Reference 0.89(0.74,1.08) 0.95(0.79,1.14) 0.93(0.77,1.12) 0.681
   Adjusted model 2 Reference 1.07(0.87,1.31) 1.20(0.98,1.48) 1.24(0.99,1.55) 0.189
  Elevated fasting glucose
   Crude model Reference 0.90(0.73,1.11) 0.82(0.67,1.01) 0.89(0.73,1.10) 0.330
   Adjusted model 2 Reference 1.02(0.82,1.28) 0.96(0.76,1.21) 1.11(0.87,1.41) 0.661
  Elevated triglycerides
   Crude model Reference 1.05(0.86,1.29) 1.12(0.92,1.36) 1.08(0.89,1.32) 0.723
   Adjusted model 2 Reference 1.03(0.83,1.28) 1.10(0.88,1.36) 1.00(0.79,1.26) 0.784
  Reduced HDL-C 4
   Crude model Reference 1.05(0.83,1.35) 1.16(0.91,1.47) 0.99(0.78,1.27) 0.547
   Adjusted model 2 Reference 1.17(0.91,1.52) 1.29(0.99,1.68) 1.15(0.87,1.53) 0.291

* p < 0.05, ** p < 0.001. 1 The p-value for the trend was examined using the medians in each quartile of dietary iron intake. 2 The models were adjusted for age, sex, income, physical activity level, intentional physical exercise, smoking status, alcohol use and dietary total energy intake. 3 The p-value for the interaction was tested for the quartiles of dietary iron intake by gender. 4 HDL-C: high-density lipoprotein-cholesterol.